Baxter International Files 2024 10-K

Ticker: BAX · Form: 10-K · Filed: Feb 21, 2025 · CIK: 10456

Sentiment: neutral

Topics: 10-K, annual-report, healthcare

Related Tickers: BAX

TL;DR

BAX 2024 10-K is in. Full financials and ops details for the year.

AI Summary

Baxter International Inc. filed its 2024 10-K on February 21, 2025, reporting on its fiscal year ending December 31, 2024. The company, headquartered in Deerfield, IL, operates in the surgical and medical instruments sector. Key financial details and operational performance for the year are outlined in this comprehensive filing.

Why It Matters

This filing provides investors and stakeholders with a detailed overview of Baxter's financial health, operational performance, and strategic direction for the fiscal year 2024.

Risk Assessment

Risk Level: medium — The filing is a standard annual report and does not inherently indicate new risks beyond those typically associated with a company of this size and industry.

Key Numbers

Key Players & Entities

FAQ

What was Baxter International Inc.'s total revenue for the fiscal year 2024?

The provided text does not contain specific revenue figures for fiscal year 2024.

What is Baxter International Inc.'s primary business segment?

Baxter International Inc. is classified under Standard Industrial Classification code 3841, which pertains to Surgical & Medical Instruments & Apparatus.

When did Baxter International Inc. file its 2024 10-K report?

Baxter International Inc. filed its 2024 10-K report on February 21, 2025.

Where is Baxter International Inc. headquartered?

Baxter International Inc.'s business and mail address is located at One Baxter Parkway, Deerfield, IL 60015.

What was the previous name of Baxter International Inc.?

Baxter International Inc. was formerly known as Baxter Travenol Laboratories Inc. and Baxter Laboratories Inc.

Filing Details

This Form 10-K (Form 10-K) was filed with the SEC on February 21, 2025 regarding BAXTER INTERNATIONAL INC (BAX).

View full filing on EDGAR

View Full Filing

View this 10-K filing on SEC EDGAR

View on Read The Filing